
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The TYPHOON study from Paris – as reported by Christian Spaulding – shows sirolimus eluting stents can halve major adverse cardiac events in patients with myocardial infarction treated with primary angioplasty. John Phoenix from St Joseph’s Hospital in Phoenix gave Sarah Maxwell his thoughts on this study.


